CTRI/2018/10/016023Not yet recruiting未知
Randomized controlled trial comparing efficacy of intranasal versus intramuscular midazolam in terminating seizure during pre surgical epilepsy VEEG monitoring
Trial Snapshot
- Phase
- 未知
- Status
- Not yet recruiting
- Sponsor
- AIIMS
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •All age groups patients with drug refractory epilepsy admitted in epilepsy monitoring unit for Video EEG , AIIMS New Delhi
Exclusion Criteria
- •1.Patients with chronic kidney and liver disease
- •2.Patients with shock, hypotension and known respiratory illness.
- •3. Acute precipitant of seizure was major trauma, hypoglycemia, cardiac arrest or heart rate less than 40 beats per minute.
- •4.Pregnant patients
- •5.Patients known allergic to midazolam.
- •6. Patients with known Coagulopathy
Investigators
Similar Trials
Completed
Not Applicable
Randomized-controlled trial comparing efficacy of new treatment using skin-wrapping sheet with conventional guideline-adhesion treatment for pressure sorepressure ulcerJPRN-UMIN000002658Higashi-Washinomiya Hospital140
Completed
Not Applicable
Randomised Controlled Trial comparing the efficacy of Pidotimod versus placebo in children with persistent asthma.CTRI/2018/04/013405Postgraduate Institute Of Medical Education and Research79
Recruiting
Phase 2
treatment of huge swelling of arm by using bandages and comparing it with placement of artificial tubes for drainage of fluidCTRI/2018/03/012510Department of surgical disciplines AIIMS NEW DELHI
Not yet recruiting
Not Applicable
Comparison of efficacy of two insulin regimens in Patients of Acute Stroke with hyperglycemiaCTRI/2019/03/017919Smruti Babtiwale
Completed
Phase 3
Randomized Controlled Trial Comparing Efficacy of Sorafenib versus Sorafenib In combination with Low dose cisplatin /fluorouracil hepatic arterial InfUSion chemotherapy in Patients with Advanced Hepatocellular Carcinoma(SILIUS Phase III)HCCJPRN-UMIN000004315SILIUS Trial Group,Japan Ministry of Health, Labour and Welfare190
